|
業務類別
|
-- |
|
業務概覽
|
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company's product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. In addition, It is also focused to develop therapies that are intended to provide functional cures for hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1). |
| 公司地址
| 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118 |
| 電話號碼
| +1 431 890-6360 |
| 傳真號碼
| +1 431 890-6399 |
| 公司網頁
| https://www.hookipapharma.com |
| 員工數量
| 10 |
| Dr. Malte Peters, M.D. |
Director, Chief Executive Officer and President |
美元 281.38K |
28/02/2025 |
| Ms. Terry Coelho |
Director, Executive Vice President, Principal Accounting Officer and Chief Financial Officer |
美元 214.77K |
28/02/2025 |
| Mr. Mark Winderlich |
Chief Development Officer |
-- |
26/04/2024 |
| Mr. Roman Necina |
Chief Operations Officer |
-- |
26/04/2024 |
| Mr. Klaus Orlinger |
Chief Scientific Officer |
-- |
26/04/2024 |
|
|
| Dr. David Ross Kaufman, M.D.,PhD |
Independent Director |
28/02/2025 |
| Dr. Malte Peters, M.D. |
Director, Chief Executive Officer and President |
28/02/2025 |
| Ms. Terry Coelho |
Director, Executive Vice President, Principal Accounting Officer and Chief Financial Officer |
28/02/2025 |
| Ms. Julie O'Neill |
Non Executive Chairman of the Board |
28/02/2025 |
| Mr. Sean A. Cassidy |
Independent Director |
28/02/2025 |
|
|
|
|
